Please login to the form below

Not currently logged in

risk-based monitoring

This page shows the latest risk-based monitoring news and features for those working in and with pharma, biotech and healthcare.

Less is more: how risk-based monitoring is changing trials

Less is more: how risk-based monitoring is changing trials

approval on risk-based monitoring (RBM) and has encouraged pharma companies and contract research organisations to start building it into trial designs. ... The last couple of years has seen increased adoption of risk-based monitoring.

Latest news

  • Harnessing clinical data Harnessing clinical data

    TransCelerate's initiatives  . Risk-based monitoring. Shared site qualification and training. Shared investigator platform. ... use of real-time, risk-based monitoring (RBM) of investigator sites.

  • Taking contract research’s pulse Taking contract research’s pulse

    The biggest change in the operating environment for clinical CROs this year was arguably final FDA guidance on risk-based monitoring to improve patient protection in trials . ... We're seeing a lot of interest in risk-based monitoring,” said Cutler,

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    As the volume and variety of data increases, clinical research will require new approaches to automate monitoring. ... Traditional source document verification, for example, is already ceding to risk-based monitoring approaches.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...